Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Labcorp Holdings Inc LH

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious disease, women's health, pharmacogenetics, parentage and donor testing, occupational testing services, medical drug monitoring services, chronic disease programs, and kidney stone prevention tests; and health and wellness services to employers and managed care organizations. In addition, the company...


NYSE:LH - Post by User

Bullboard Posts
Next >>
User Avatar Image
(6)
•••
  • WilliamAcerX
Post by WilliamAceron Sep 14, 2020 9:21am
202 Views
Post# 31551786

September 14, 2020 3:01 AM Victory Square Technologies

September 14, 2020 3:01 AM Victory Square Technologies

Victory Square Technologies Portfolio Company Receives Approval for Sale and Use of Safetest Covid-19 Antibody Test for the European Union

  • Victory Square Health received CE from EU competent authority of Belgium  for Safetest ELISA antibody test for distribution, sale, and usage in the European Union
  • Safetest Covid-19™ test enables the user to verify whether they are currently infected, have been infected or have never been infected with Covid-19
  • This approval now enables Victory Square Health to distribute throughout the 27 countries and 446M inhabitants which make up the European Union
  • Victory Square Health received FDA permission to sell and market on August 14 and received Anvisa approval for Sale & Use of Safetest Covid-19 Antibody Test for the Country of Brazil on September 8.

Bullboard Posts
Next >>